Repurposing the FDA-approved raloxifene to potentiate gemcitabine cytotoxicity in pancreatic cancer

被引：0
|
作者：
Trinh, Jessica [1 ]
Badejo, Adeleke [2 ]
Love, Quintin [2 ]
True, Heather [2 ]
Rao, Deepa [2 ]
Malhotra, Ashim [2 ]
机构：
[1] Pacific Univ, Forest Grove, OR USA
[2] Pacific Univ, Sch Pharm, Hillsboro, OR USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1212
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Repurposing the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
    Ding, Andy S.
    Casaos, Joshua
    Huq, Sakibul
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications
    Cai, Lu
    NUTRIENTS, 2023, 15 (11)
  • [33] Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
    Chopra, Sidharth
    Torres-Ortiz, Maria
    Hokama, Leslie
    Madrid, Peter
    Tanga, Mary
    Mortelmans, Kristien
    Kodukula, Krishna
    Galande, Amit K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2598 - 2601
  • [34] FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer
    Wang, Jian
    Yu, Nianhui
    Tang, Yunpeng
    Cheng, Yingsheng
    Li, Hui
    PHARMACEUTICALS, 2024, 17 (12)
  • [35] Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
    Badr, Haitham A.
    AlSadek, Dina M. M.
    Darwish, Ashraf A.
    ElSayed, Abdelaleim I.
    Bekmanov, Bakhytzhan O.
    Khussainova, Elmira M.
    Zhang, Xueji
    Cho, William C. S.
    Djansugurova, Leyla B.
    Li, Chen-Zhong
    EXPERT REVIEW OF PROTEOMICS, 2014, 11 (02) : 227 - 236
  • [36] Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma
    Ponzini, Francesca M.
    Schultz, Christopher W.
    Leiby, Benjamin E.
    Cannaday, Shawnna
    Yeo, T.
    Posey, James
    Bowne, Wilbur B.
    Yeo, Charles
    Brody, Jonathan R.
    Lavu, Harish
    Nevler, Avinoam
    BMJ OPEN, 2023, 13 (10):
  • [37] Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials
    Pertusati, Fabrizio
    Pileggi, Elisa
    Richards, Jennifer
    Wootton, Mandy
    Van Leemputte, Thijs
    Persoons, Leentje
    De Coster, David
    Villanueva, Xabier
    Daelemans, Dirk
    Steenackers, Hans
    McGuigan, Christopher
    Serpi, Michaela
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 2864 - 2878
  • [38] Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
    Benedict, Ashwini
    Bansal, Neha
    Senina, Svetlana
    Hooper, Idris
    Lundberg, Lindsay
    de la Fuente, Cynthia
    Narayanan, Aarthi
    Gutting, Bradford
    Kehn-Hall, Kylene
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [39] Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs
    Famurewa, Ademola C.
    Mukherjee, Anirban Goutam
    Wanjari, Uddesh Ramesh
    Sukumar, Aarthi
    Murali, Reshma
    Renu, Kaviyarasi
    Vellingiri, Balachandar
    Dey, Abhijit
    Gopalakrishnan, Abilash Valsala
    LIFE SCIENCES, 2022, 305
  • [40] Discovery of new Glyoxalase I inhibitors by repurposing of FDA-approved drugs: An in silico study
    Hoseyni, Khaled
    Sepehri, Bakhtyar
    Irani, Mehdi
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1312
12345